This article describes a meta-analysis of published associations between depression and
heart failure (HF) in regard to 3 questions: 1) What is the prevalence of depression among …

Heart failure is a global public health problem that affects more than 26 million people worldwide.
The global burden of heart failure is growing and is expected to increase substantially …

Background— Adeno-associated virus type 1/sarcoplasmic reticulum Ca 2+ -ATPase was
assessed in a randomized, double-blind, placebo-controlled, phase 2 study in patients with …

Objectives : We sought to evaluate the characteristics, treatments, and outcomes of patients
with preserved and reduced systolic function heart failure (HF). Background : Heart failure …

Objective. —To study the potential usefulness of the 6-minute walk test, a self-paced
submaximal exercise test, as a prognostic indicator in patients with left ventricular dysfunction. …

ContextThe association between systolic blood pressure (SBP) at admission, clinical
characteristics, and outcomes in patients hospitalized for heart failure who have reduced or …

OBJECTIVES The present analysis examines the prognostic implications of moderate renal
insufficiency in patients with asymptomatic and symptomatic left ventricular systolic …

Background Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with
many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well …

It is anticipated that γ-secretase inhibitors (γ-Sec-I) that modulate Notch processing will alter
differentiation in tissues whose architecture is governed by Notch signaling. To explore this …

Background Vesnarinone, an inotropic drug, was shown in a short-term placebo-controlled
trial to improve survival markedly in patients with severe heart failure when given at a dose of …